Patellar resurfacing after endoprosthetic replacement for primary or secondary bone tumors. by Liddle, AD
© Annals of Translational Medicine. All rights reserved. Ann Transl Med 2016;4(21):435atm.amegroups.com
Page 1 of 3
Commentary
Patellar resurfacing after endoprosthetic replacement for primary 
or secondary bone tumors
Alexander D. Liddle
Institute of Orthopaedics and Musculoskeletal Sciences, University College London, Royal National Orthopaedic Hospital, Stanmore, Middlesex 
HA7 4LP, UK
Correspondence to: Alexander D. Liddle. University College London Institute of Orthopaedics and Musculoskeletal Sciences, Royal National 
Orthopaedic Hospital, Stanmore, Middlesex HA7 4LP, UK. Email: a.liddle@ucl.ac.uk.
Submitted Oct 02, 2016. Accepted for publication Oct 09, 2016.
doi: 10.21037/atm.2016.11.23
View this article at: http://dx.doi.org/10.21037/atm.2016.11.23
The question of whether or not to resurface the patella 
during primary total knee replacement (TKR) is an 
enduring controversy in orthopaedic surgery (1-4). Opinion 
is divided—some surgeons will routinely resurface the 
patella, some will never resurface and the remainder will 
resurface or not on the basis of the appearance of the 
patella at operation or the location of the patient’s pain. 
Osteoarthritis (OA), the most common indication for 
TKR, is considered to be a disease of the whole joint and 
proponents of resurfacing suggest that the whole joint 
should be treated; indeed, a proportion of cases in whom 
patellar resurfacing is not performed will later go on to 
undergo secondary resurfacing. Those who do not tend 
to resurface the patella point to the morbidity associated 
with patellar resurfacing, which may predispose to patellar 
fracture and extensor mechanism rupture (5). On the basis 
of the current evidence, patellar resurfacing appears to have 
a small effect the overall rate of revision following surgery 
(probably as a result of eliminating secondary resurfacing), 
but has little or no effect on patient-reported outcome 
measures (PROMs) after TKR (2).
Patients undergoing endoprosthetic replacement (EPR) 
for primary or secondary bone tumors differ from those 
undergoing TKR for OA in a number of features; they 
are generally younger, have higher levels of pre-operative 
function and importantly, have no ongoing disease process 
within the knee joint. They also have a high rate of extensor 
mechanism—related complications as EPRs require 
extensive soft tissue and bony resections, and patella alta 
or baja can result from inadequate restoration of the native 
joint line. In this context, it would appear to make intuitive 
sense to leave the patella unresurfaced. However, even 
in an essentially normal patella, articulation of cartilage 
against the metal of the implant can lead to symptomatic 
degenerative change in the patellar cartilage, exposing the 
patient to the need for further surgery with its attendant 
risks.
The study of Etchebehere et al. published in the Journal 
of Bone and Joint Surgery in April of this year attempts 
to bring some clarity to the issue (6). They present the 
results of a retrospective series of 108 patients who had 
undergone distal femoral EPR for neoplastic disease (in 
most cases, a primary malignancy of bone, most commonly 
osteosarcoma), with a mean follow-up of 4.5 years. Of the 
108 patients, 48 (44%) had undergone patellar resurfacing. 
The patients in the two groups were broadly comparable 
aside from a large difference in age (with the non-
resurfaced group being significantly younger, with a mean 
age of 28 years, compared to 41 years in the resurfaced 
group), and surgical approach (with 65% of patients in 
the non-resurfaced group having undergone their surgery 
through a medial approach and 83% in the resurfaced 
group undergoing their surgery through a lateral approach). 
The primary outcome was patella-related knee function, 
with three measures (the presence of documented anterior 
knee pain or extensor lag, and the range of movement) 
reported at 1 year.  Secondary outcomes included 
patella-related complications (symptomatic instability 
or clunking, radiographic evidence of subluxation, 
dislocation, degeneration or impingement), patella-related 
reoperations and general functional outcome measured 
using the Musculoskeletal Tumor Society scale (7). Baseline 
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differences between the groups were addressed using a 
linear regression model. 
The authors report no significant differences between 
the groups in the incidence of anterior knee pain, range of 
movement or extensor lag. Around half (48%) of patients 
in the non-resurfaced group had radiographic evidence 
of patellar OA but this was not associated with symptoms 
(although future problems cannot be discounted as follow-
up was only short-term). Complications, patellar height, 
need for patella-related reoperation and final functional 
outcome were similar in the two groups. The only other 
significant difference between the two groups was a higher 
incidence of peripatellar calcifications in the resurfacing 
group—this was not associated with pain and the clinical 
significance of this radiographic finding is unclear.
Clearly, the study design is not without its limitations—
this was a retrospective study with significant imbalance 
in covariates between groups, the follow-up was short, 
functional scores were only available in around half of the 
patients, we do not know why surgeons elected to resurface 
some patellae and not others, and patients were not directly 
asked about patellofemoral symptoms, which may explain 
the lower overall rate of such symptoms when compared to 
previous series (8). A prospective, and ideally, randomized 
trial would be the optimal design to answer this question—
however, the rarity of the condition and the low overall rate 
of patella-related complications would render this extremely 
challenging. 
Within these constraints, the authors have produced 
an important study. It is the largest series examining this 
question to date and is the first to examine the relationship 
between function and patellar resurfacing whilst adjusting 
for baseline differences between the two groups. It is 
unlikely to change practice amongst oncologic knee 
surgeons—the authors conclude that, in the absence 
of a clear advantage to either strategy, surgeons should 
continue to exercise their clinical judgement as to whether 
to resurface the patella—but it gives us the best evidence 
yet to support current practice. One additional and striking 
finding evident from this study and from the existing 
literature is that the rate of patellar complications is high 
in this cohort with 16% having subluxation or dislocation 
of the patella, 23% having patellar impingement and 22% 
having other patellar complications such as fracture and 
arthrofibrosis in this study alone. It seems clear that surgical 
technique, particularly in terms of achieving optimal 
rotation of the femoral component and restoration of the 
joint line, is substantially more important than the choice 
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